MX9305933A - Metodo para antagonizar al 1,4,5-trifosfato de inositol. - Google Patents

Metodo para antagonizar al 1,4,5-trifosfato de inositol.

Info

Publication number
MX9305933A
MX9305933A MX9305933A MX9305933A MX9305933A MX 9305933 A MX9305933 A MX 9305933A MX 9305933 A MX9305933 A MX 9305933A MX 9305933 A MX9305933 A MX 9305933A MX 9305933 A MX9305933 A MX 9305933A
Authority
MX
Mexico
Prior art keywords
inositol
triphosphate
antagonize
oligometers
formula
Prior art date
Application number
MX9305933A
Other languages
English (en)
Spanish (es)
Inventor
Kenneth A Stauderman
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of MX9305933A publication Critical patent/MX9305933A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/795Polymers containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyurethanes Or Polyureas (AREA)
MX9305933A 1992-09-28 1993-09-27 Metodo para antagonizar al 1,4,5-trifosfato de inositol. MX9305933A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95239392A 1992-09-28 1992-09-28

Publications (1)

Publication Number Publication Date
MX9305933A true MX9305933A (es) 1994-04-29

Family

ID=25492868

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9305933A MX9305933A (es) 1992-09-28 1993-09-27 Metodo para antagonizar al 1,4,5-trifosfato de inositol.

Country Status (13)

Country Link
EP (1) EP0661982A1 (Direct)
JP (1) JPH08502068A (Direct)
KR (1) KR950703347A (Direct)
AU (1) AU670962B2 (Direct)
CA (1) CA2145681A1 (Direct)
HU (1) HUT70192A (Direct)
IL (1) IL107066A (Direct)
MX (1) MX9305933A (Direct)
NO (1) NO951163L (Direct)
NZ (1) NZ256178A (Direct)
TW (1) TW260663B (Direct)
WO (1) WO1994007507A1 (Direct)
ZA (1) ZA936978B (Direct)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2978995A (en) * 1994-06-30 1996-01-25 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Methods for treating cell proliferative disorders by modulating signal transduction
US5780483A (en) * 1995-02-17 1998-07-14 Smithkline Beecham Corporation IL-8 receptor antagonists
JPH11503110A (ja) 1995-02-17 1999-03-23 スミスクライン・ビーチャム・コーポレイション Il−8受容体拮抗剤
US6083920A (en) * 1995-12-21 2000-07-04 Ayurcore, Inc. Compositions for modulating intracellular inositol trisphosphate concentration
US6005008A (en) * 1996-02-16 1999-12-21 Smithkline Beecham Corporation IL-8 receptor antagonists
US6262113B1 (en) 1996-03-20 2001-07-17 Smithkline Beecham Corporation IL-8 receptor antagonists
US6211373B1 (en) 1996-03-20 2001-04-03 Smithkline Beecham Corporation Phenyl urea antagonists of the IL-8 receptor
CZ425598A3 (cs) * 1996-06-27 1999-08-11 Smithkline Beecham Corporation Antagonista IL-8 receptoru
BR9709938A (pt) 1996-06-27 1999-08-10 Smithkline Beecham Corp Antagonistas dos receptores de il-8
ATE358486T1 (de) * 2000-11-09 2007-04-15 Contrimmune Biotechnology Inc Verwendung von xestospongin c zur behandlung oder vorbeugung einer hiv-infektion
CA2857374A1 (en) 2011-09-02 2013-03-07 The Trustees Of Columbia University In The City Of New York Camkii, ip3r, calcineurin, p38 and mk2/3 inhibitors to treat metabolic disturbances of obesity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB781479A (en) * 1953-08-27 1957-08-21 Ciba Ltd New polyureas and process for making them
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers

Also Published As

Publication number Publication date
CA2145681A1 (en) 1994-04-14
IL107066A0 (en) 1993-12-28
EP0661982A1 (en) 1995-07-12
TW260663B (Direct) 1995-10-21
HU9500891D0 (en) 1995-05-29
ZA936978B (en) 1994-04-18
IL107066A (en) 1998-01-04
JPH08502068A (ja) 1996-03-05
NZ256178A (en) 1997-03-24
NO951163D0 (no) 1995-03-27
HUT70192A (en) 1995-09-28
AU4841793A (en) 1994-04-26
WO1994007507A1 (en) 1994-04-14
NO951163L (no) 1995-03-27
KR950703347A (ko) 1995-09-20
AU670962B2 (en) 1996-08-08

Similar Documents

Publication Publication Date Title
DE69324859D1 (de) Verwendung von Lipid-gebundener Glykoaminoglykanen zur Behandlung der rheumatoider Arthritis
MX9305933A (es) Metodo para antagonizar al 1,4,5-trifosfato de inositol.
ATE206919T1 (de) Verwendung des wirkstoffs flupirtin zur herstellung eines arzneimittels zur bekämpfung von muskelverspannungen
CU23393A3 (es) Compuestos inhibidores de la raf kinasa y composiciones farmacéuticas que los contienen
BR0116001A (pt) Métodos para tratar distúrbios neuropsiquiátricos com antagonistas receptores nmda
ES2135083T3 (es) Trifeniletilenos para la prevencion y el tratamiento de la osteoporosis.
ES2120993T3 (es) Agentes antitromboticos.
DE69022953D1 (de) Zusammensetzungen zur Behandlung von Fettablagerungen.
ES2116436T3 (es) Carbamatos y agentes protectores de las plantas que les contienen.
PT729468E (pt) Antagonistas nao peptidicos de receptores de taquiquininas
MX9202181A (es) Compuestos arilicos y heteroarilicos bis mono y biciclicos que inhiben la tirosina quinasa de receptor de egf y/o pdgf.
ES2070981T3 (es) Concentrados de componente activo y nuevas combinaciones de componente activo de hojas de ginkgo biloba, sus metodos de preparacion y productos farmaceuticos que contienen los concentrados de componente activo o las combinaciones de componente activo.
ES2079719T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su utilizacion y agentes que los contienen en calidad de anticoagulantes.
PT841928E (pt) Formulacao de libertacao prolongada de d-trep-metilfenidato
PA8443001A1 (es) Prevencion de la perdida y restauracion de la masa osea por determinados agonistas de prostaglandinas
ATE211384T1 (de) Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
ES2058346T3 (es) Compuestos piperidinilicos 1,4-disustituidos.
DE59306745D1 (de) Beobachtung von prüflingsoberflächen nach dem speckle-shearing-verfahren
GB2223169B (en) Inositol trisphosphate for the treatment of bone disorders
MX9401175A (es) Inhibidores de la acetilcolinesterasa sililada.
ES2011427T3 (es) Derivados de la oxima de octahidronaftaleno para la inhibicion de la sintesis del colesterol, procedimientos para su preparacion y composiciones que los contienen.
MX9301298A (es) Seudopeptidos, procedimiento para su preparacion y composicion farmaceutica que los contiene.
BR8902892A (pt) Processo para a preparacao de hidrazinas substituidas e composicao inseticida
DE69432124D1 (de) Verwendung eines inositoltriphosphatester, zur herstellung eines medikamentes
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante